Dr. James Calmes, MD, MBA
What this data tells you about Dr. Calmes
Dr. James Calmes is a rheumatology in Lubbock, TX, with 20 years in practice. Based on federal Medicare data, Dr. Calmes performed 45,739 Medicare services across 2,713 unique beneficiaries.
Between the years covered by Open Payments, Dr. Calmes received a total of $6,772 from 25 pharmaceutical and/or device companies across 543 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Calmes is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) | 23,145 | $11 | $49 |
| Denosumab injection (Prolia/Xgeva) | 11,220 | $18 | $35 |
| Infliximab infusion (Remicade) | 7,302 | $24 | $200 |
| Office visit, established patient (20-29 min) | 593 | $57 | $140 |
| Blood draw (venipuncture) | 496 | $7 | $7 |
| Complete blood count (CBC) with differential | 401 | $7 | $25 |
| Administration of chemotherapy into vein, each additional hour | 348 | $21 | $70 |
| Comprehensive metabolic blood panel | 321 | $10 | $35 |
| Administration of chemotherapy into vein, 1 hour or less | 256 | $95 | $300 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 245 | $4 | $12 |
| C-reactive protein test (inflammation marker) | 192 | $5 | $36 |
| Drug injection, under skin or into muscle | 192 | $11 | $50 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 138 | $48 | $125 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 129 | $17 | $50 |
| Vitamin D level test | 105 | $27 | $80 |
| Office visit, established patient (30-39 min) | 105 | $85 | $207 |
| Measurement of complement (immune system proteins), antigen, | 86 | $11 | $35 |
| Automated urinalysis | 61 | $2 | $10 |
| Rheumatoid factor level | 56 | $5 | $20 |
| Basic metabolic blood panel | 45 | $8 | $30 |
| New patient office visit (45-59 min) | 43 | $107 | $318 |
| Liver function blood test panel | 38 | $7 | $25 |
| X-ray of hand, 2 views | 36 | $21 | $50 |
| Blood creatinine level | 34 | $5 | $15 |
| Measurement of dna antibody, native or double stranded | 33 | $13 | $40 |
| Bone density scan (DEXA) | 30 | $36 | $200 |
| X-ray of knee, 1-2 views | 26 | $25 | $62 |
| Creatine kinase (cardiac enzyme) level, total | 20 | $6 | $20 |
| Uric acid level test | 17 | $4 | $15 |
| Acute hepatitis panel | 13 | $47 | $140 |
| Calcium level, total | 13 | $5 | $15 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Calmes is a mixed practice specialist, with above-average Medicare volume (top 25% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Calmes experienced with golimumab infusion (simponi aria)?
Does Dr. Calmes receive payments from pharmaceutical companies?
How do Dr. Calmes's costs compare to other rheumatologys in Lubbock?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology